ADRENAL: Difference between revisions

ADRENAL (view source)

49 bytes removed , 30 January 2018

1,567

edits

@@ Line 41: / Line 41: @@
 ==Design==
-<!-- This section provides a bulleted-list summary of your trial's design. Use the ACCORD trial as a template. Don't worry about the asterisks; they're just bullets for a bulleted list. -->
+* International, Multicenter, double-blind, parallel-group, randomized, controlled trial
+* N=3800
-* Multicenter, double-blind, parallel-group, randomized, controlled trial
+** Hydrocortisone (n=1832)
-* N=
+** Placebo (n=1826)
-** Intervention (n=)
+* Setting: Australia (45 sites), UK (12), New Zealand (8),
-** Placebo (n=)
+Saudi Arabia (3), and Denmark (1)
-* Setting:
+* Enrollment: March 2013 to April 2017
-* Enrollment:
+* Mean follow-up: 90 days
-* Mean follow-up:
+* Analysis: ITT
-* Analysis:
+* Primary Outcome: 90 day mortality
-* Primary Outcome:
-* Secondary Outcomes:
 ==Population==